MedTrace Logo

Safety and Usability of the EXPLORER Exoskeleton in Adults With Neuromuscular Diseases

NCT06894160 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2025-06-04

No results posted yet for this study

Summary

Neurodevelopmental disorders frequently result in abnormal development of the Central Nervous System (CNS), often leading to motor impairments such as difficulty in standing and walking. EXPLORER is a robotic exoskeleton for gait rehabilitation, specifically designed for adults aged 18 to 85 with motor disabilities.The aim of this study is to evaluate the safety and usability of the EXPLORER for adults with motor disability.

Conditions

  • Neuromuscular Disorders

Interventions

DEVICE

Adults EXPLORER

Two sessions with the robotic gait device in patients with neuromuscular diseases.

Sponsors & Collaborators

  • Hospital Universitario La Paz

    collaborator OTHER

  • MarsiBionics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2025-07-15
Completion
2025-08-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06894160 on ClinicalTrials.gov